scholarly journals Bone marrow cells play only a very minor role in chronic liver regeneration induced by a choline-deficient, ethionine-supplemented diet

2008 ◽  
Vol 1 (3) ◽  
pp. 195-204 ◽  
Author(s):  
Joanne N. Tonkin ◽  
Belinda Knight ◽  
David Curtis ◽  
Lawrence J. Abraham ◽  
George C.T. Yeoh
PLoS ONE ◽  
2019 ◽  
Vol 14 (1) ◽  
pp. e0210588 ◽  
Author(s):  
Tatsuro Nishimura ◽  
Taro Takami ◽  
Ryo Sasaki ◽  
Yuki Aibe ◽  
Takashi Matsuda ◽  
...  

2002 ◽  
Vol 36 (5) ◽  
pp. 653-659 ◽  
Author(s):  
Hideaki Fujii ◽  
Tetsuro Hirose ◽  
Shoshiro Oe ◽  
Kentaro Yasuchika ◽  
Hisaya Azuma ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Carolina Uribe-Cruz ◽  
Carlos Oscar Kieling ◽  
Mónica Luján López ◽  
Alessandro Osvaldt ◽  
Gustavo Ochs de Muñoz ◽  
...  

Background and Aims. The use of bone marrow cells has been suggested as an alternative treatment for acute liver failure. In this study, we investigate the effect of encapsulated whole bone marrow cells in a liver failure model.Methods. Encapsulated cells or empty capsules were implanted in rats submitted to 90% partial hepatectomy. The survival rate was assessed. Another group was euthanized at 6, 12, 24, 48, and 72 hours after hepatectomy to study expression of cytokines and growth factors.Results. Whole bone marrow group showed a higher than 10 days survival rate compared to empty capsules group. Gene expression related to early phase of liver regeneration at 6 hours after hepatectomy was decreased in encapsulated cells group, whereas genes related to regeneration were increased at 12, 24, and 48 hours. Whole bone marrow group showed lower regeneration rate at 72 hours and higher expression and activity of caspase 3. In contrast, lysosomal-β-glucuronidase activity was elevated in empty capsules group.Conclusions. The results show that encapsulated whole bone marrow cells reduce the expression of genes involved in liver regeneration and increase those responsible for ending hepatocyte division. In addition, these cells favor apoptotic cell death and decrease necrosis, thus increasing survival.


2014 ◽  
Vol 59 (7) ◽  
pp. 1484-1489 ◽  
Author(s):  
Masaki Kaibori ◽  
Yasushi Adachi ◽  
Tomohiko Shimo ◽  
Morihiko Ishizaki ◽  
Kosuke Matsui ◽  
...  

Cell Reports ◽  
2017 ◽  
Vol 18 (1) ◽  
pp. 107-121 ◽  
Author(s):  
Elisa Pedone ◽  
Vlad-Aris Olteanu ◽  
Lucia Marucci ◽  
Maria Isabel Muñoz-Martin ◽  
Sameh A. Youssef ◽  
...  

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 2338-2338
Author(s):  
Jan Schulte am Esch ◽  
Wolfram T. Knoefel ◽  
Michael Klein ◽  
Alireza Ghodsizad ◽  
Guenter Fuerst ◽  
...  

Abstract The liver has a large capacity for regeneration after surgical resection. However, below a critical level of future liver remnant volume, liver resection is accompanied by significant increase of postoperative liver failure and mortality. There is accumulating evidence for the contribution of hematopoetic stem cells to participate in liver regeneration. Here we report on three patients that were subjected to intra portal application of CD133+ bone marrow stem cells to support a standard concept of preoperative proliferation of the prospective liver mass. In all three cases, scheduled for right hepatic trisegmentectomy, isolated portal venous embolisation (PVE) of liver segments I and IV–VIII routinely utilized to expand left lateral hepatic segments II/III (prospective remaining liver mass) was questionably sufficient. Autologous bone marrow cells were enriched for stem cell marker CD133 utilizing an immunomagnetic device. For characterisation, each preparation of Cells was subjected to FACS-analyses for markers CD34, CD45 and CD133. Absolute numbers of 2.4 to 12.3 mio CD133+ cells were porto-venously applied to the left-lateral liver segments following PVE of contra lateral liver segments. The treatment with CD133+ was well tolerated without obvious side effects. CT-scan volumetry revealed 2.5 fold increased mean proliferation rates of left-lateral segments when compared to a group of three consecutive patients, treated with the same therapeutic concept - except the application of stem cells. Two to three weeks after intervention, future remnant liver volume was sufficient to perform expanded liver resection, which was applied safely to all patients. This first experience with a novel concept of portovenous application of CD133+ bone marrow cells subsequent to porto-venous embolisation encourages to carry out future controlled trials to evaluate the effectiveness of this approach to boost liver regeneration processes.


2011 ◽  
Vol 25 (1) ◽  
pp. 54-60 ◽  
Author(s):  
Elida Gripp Mannheimer ◽  
Luiz Fernando Quintanilha ◽  
Adriana Bastos Carvalho ◽  
Bruno Diaz Paredes ◽  
Felipe Gonçalves de Carvalho ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document